Preprotachykinin Activators

Common Preprotachykinin Activators include, but are not limited to Retinoic Acid, all trans CAS 302-79-4, Forskolin CAS 66575-29-9, Dibutyryl-cAMP CAS 16980-89-5, Dexamethasone CAS 50-02-2 and Kainic acid monohydrate CAS 58002-62-3.

Preprotachykinin activators are compounds that stimulate the expression or activity of preprotachykinin, a precursor protein that gives rise to several tachykinin peptides. Tachykinins are a family of neuropeptides known for their ability to mediate various physiological processes, including the modulation of pain sensation, smooth muscle contraction, salivation, and inflammation. The primary tachykinins found in preprotachykinin include Substance P, Neurokinin A, and Neurokinin B.

The biogenesis of these tachykinins begins with the transcription of the preprotachykinin gene. Once translated, the resulting protein undergoes a series of enzymatic cleavages and modifications to produce the active tachykinin peptides. Substance P, one of the most extensively studied tachykinins, plays a significant role in transmitting pain signals in the central nervous system and has been implicated in various inflammatory processes. The expression and release of tachykinins, especially Substance P, are tightly regulated, ensuring appropriate responses to physiological stimuli. Preprotachykinin activators, by promoting the expression or processing of this precursor protein, can enhance the availability of tachykinin peptides in the system. Given the breadth of physiological processes modulated by tachykinins, the role of preprotachykinin activators in influencing these pathways is of significant interest. Delving into the molecular mechanisms by which these activators function and the subsequent effects on tachykinin signaling provides a comprehensive understanding of neuropeptide regulation, offering insights into the complex interplay of signaling molecules in various physiological and cellular contexts.